Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn New India Regulatory News (ANII)

Share Price Information for Abrdn New India (ANII)

Share Price is delayed by 15 minutes
Get Live Data
664.00    0.00 (0.00%)
Bid:
666.00
Ask:
672.00
Spread: 6.00 (0.901%)
Market Cap: £288.06m
ANII Live PriceLast checked at - London Stock Exchange

Intraday Abrdn New India Share Chart

Directorate Change

20 Nov 2024 14:30

RNS Number : 0150N
abrdn New India Investment Trust
20 November 2024
 

ABRDN NEW INDIA INVESTMENT TRUST PLC

LEI - 549300D2AW66WYEVKF02

 

Appointment of Non-Executive Director

 

20 November 2024

 

The Board of abrdn New India Investment Trust PLC (the "Company") is pleased to announce the appointment of Irina Miklavchich as an independent non-executive Director of the Company with effect from 20 November 2024 following a search conducted by an independent recruitment consultancy.

 

Irina was formerly an Executive Director in Equities Trading at UBS Investment Bank and, prior to that, she was the Head of Emerging Markets Equities desk and Fund Manager of the Global Emerging Markets Fund at Columbia Threadneedle (EMEA) for over six years. Before that, she spent eight years at Goldman Sachs, initially as an equity research analyst with the Emerging Markets and Global Financials teams at Goldman Sachs Asset Management and latterly as a portfolio manager and research analyst with Goldman Sachs Principal Strategies.

 

Irina possesses strong expertise in investing in Emerging Markets incorporating fundamental company analysis, portfolio construction and risk diversification across sectors and geographies. Through her experience in fund management, Irina has in-depth knowledge of Emerging Markets economies including China, India and Brazil, as well as other countries in Asia, Latin America and the EMEA region. 

 

Michael Hughes, Chairman of the Company, said: "The Directors are delighted to welcome Irina to the Board. Irina brings to the Company considerable and relevant investment management experience, with a particular focus on emerging market equities. The Board very much looks forward to working with Irina."

 

There are no other disclosures required to be made for Irina Miklavchich in respect of paragraphs UKLR 6.4.8R (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Irina Miklavchich, or her Persons Closely Associated, hold no interest in the Company's shares.

 

For further information, please contact:

 

Stuart Reid

abrdn Holdings Limited

Secretaries

 

Email: cef.cosec@abrdn.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZMZMDGGGDZM
Date   Source Headline
5th Jun 202612:40 pmRNSNet Asset Value(s)
4th Jun 20265:04 pmRNSTransaction in Own Shares
4th Jun 20263:01 pmRNSMonth End Net Asset Value(s)
4th Jun 202611:57 amRNSNet Asset Value(s)
3rd Jun 20265:03 pmRNSTransaction in Own Shares
3rd Jun 202611:25 amRNSNet Asset Value(s)
2nd Jun 20265:08 pmRNSTransaction in Own Shares
2nd Jun 202612:19 pmRNSNet Asset Value(s)
1st Jun 20263:44 pmRNSGearing Disclosures
1st Jun 20269:19 amRNSTotal Voting Rights
29th May 20265:16 pmRNSTransaction in Own Shares
29th May 202611:43 amRNSNet Asset Value(s)
28th May 20265:05 pmRNSTransaction in Own Shares
28th May 202611:53 amRNSNet Asset Value(s)
27th May 20265:05 pmRNSTransaction in Own Shares
27th May 202611:48 amRNSNet Asset Value(s)
26th May 20265:04 pmRNSTransaction in Own Shares
26th May 20262:45 pmRNSGearing Disclosures
26th May 202612:19 pmRNSNet Asset Value(s)
22nd May 20265:06 pmRNSTransaction in Own Shares
22nd May 20263:40 pmRNSHolding(s) in Company
22nd May 202612:09 pmRNSNet Asset Value(s)
21st May 20265:07 pmRNSTransaction in Own Shares
21st May 202611:30 amRNSNet Asset Value(s)
20th May 20265:07 pmRNSTransaction in Own Shares
20th May 202612:16 pmRNSNet Asset Value(s)
19th May 20265:05 pmRNSTransaction in Own Shares
19th May 202611:37 amRNSNet Asset Value(s)
18th May 20265:07 pmRNSTransaction in Own Shares
18th May 20264:41 pmRNSGearing disclosure
18th May 20263:52 pmRNSHolding(s) in Company
18th May 202612:15 pmRNSNet Asset Value(s)
15th May 20265:04 pmRNSTransaction in Own Shares
15th May 202612:29 pmRNSNet Asset Value(s)
15th May 202610:57 amRNSHolding(s) in Company
14th May 20265:06 pmRNSTransaction in Own Shares
14th May 202610:53 amRNSNet Asset Value(s)
13th May 20265:05 pmRNSTransaction in Own Shares
13th May 202611:19 amRNSNet Asset Value(s)
13th May 20269:09 amRNSPortfolio disclosure
12th May 20265:06 pmRNSTransaction in Own Shares
12th May 202612:35 pmRNSNet Asset Value(s)
11th May 20265:10 pmRNSTransaction in Own Shares
11th May 202612:33 pmRNSGearing disclosure
11th May 202611:31 amRNSNet Asset Value(s)
8th May 20265:04 pmRNSTransaction in Own Shares
8th May 20263:38 pmRNSHolding(s) in Company
8th May 202611:55 amRNSNet Asset Value(s)
8th May 20267:00 amRNSCompliance with Market Abuse Regulation
7th May 20265:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.